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The Frequency of CCR5delta32 Polymorphism in
the Central Black Sea Coastal Region
in a Healthy Population
Aim: Delta32 polymorphism in the chemokine receptor 5 (CCR5) gene affects human immune deficiency virus
type 1 (HIV-1) entry, transmission, and outcome. The aim of this study was to determine the allelic frequencies
of genetic variant CCR5delta32, which influence susceptibility to HIV-1 infection, in a northern Turkish
population.
Materials and Methods: We determined the allelic frequencies of CCR5delta32 in 449 unrelated healthy
individuals from the central Black Sea coastal region without any known history of HIV-1 infection. The
polymorphism was analyzed using polymerase chain reaction (PCR). The population was in the HardyWeinberg equilibrium. Delta32 allelic frequencies were calculated.
Results: The frequency of mutant delta32 allele in this population was 5.2%.
Conclusions: Our data indicate that the low frequency of CCR5delta32 allele may be related to higher genetic
susceptibility to HIV-1 infection in the central Black Sea coastal region Turkish population.
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Orta Karadeniz Bölgesi Sa¤l›kl› Türk Populasyonunda CCR5delta32 Frekans›
Amaç: Kemokin reseptör (CCR5) geninde yer alan delta32 polimorfizmi, insan immün yetmezlik sendromu
virüsünün (HIV-1) giriﬂ, bulaﬂma ve prognozunu etkiler. Bu çal›ﬂmada, kuzey Anadolu Türk populasyonunda
HIV–1 enfeksiyonlar›na yatk›nl›¤› etkileyen CCR5delta32 gen varyantlar›n›n allel frekanslar›n›n hesaplanmas›
amaçland›.
Yöntemler: Orta Karadeniz k›y› bölgesinde yaﬂayan aralar›nda akrabal›k ve HIV-1 enfeksiyonu öyküsü
olmayan 449 sa¤l›kl› bireyin CCR5delta32 allel frekanslar› hesapland›. Polimorfizm, polimeraz zincir
reaksiyonu (PCR) tekni¤i kullan›larak analiz edildi. Populasyon Hardy-Weinberg dengesindeydi. Delta32 allel
frekans› hesapland›.
Bulgular: Populasyonda mutant delta32 allelinin frekans› %5.2 olarak bulundu.
Sonuç: Bulgular›m›z düﬂük CCR5delta32 allel frekans›n›n orta Karadeniz bölgesi Türk populasyonun, HIV-1
enfeksiyonlar›na yüksek derecede yatk›nl›¤› oldu¤unu göstermektedir.
Anahtar Sözcükler: Kemokin reseptörü, delta32, Türk halk›
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The chemokine receptor 5 gene (CCR5) appears to be the major co-receptor for the
macrophage-tropic strains of human immunodeficiency virus type 1 (HIV-1). The
chemokine receptor, CCR5, is encoded by the CMKBR5 gene located on the p21.3
region of human chromosome 3. HIV-infected individuals heterozygous for
CCR5+/delta32 can significantly delay the onset of acquired immunodeficiency syndrome
(AIDS) compared with HIV-infected individuals who do not carry the delta32
polymorphism. Homozygous individuals for CCR5-delta32 allele have been found to be
highly resistant to HIV infection (1-3). A 32-bp deletion in the open reading frame of
the CCR5 gene induces a frame shift premature stop codon within the third extracellular
domain and results in a truncated protein product that is not transported to the cell
surface as a HIV-1 co-receptor (4).
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Amplified fragments for the CCR5 locus were
resolved on 2% agarose and analyzed in a video gel
documentation system (Biolabs, Kyoto, Japan) after
staining with ethidium bromide.

One thousand nine hundred and twenty-two patients
with AIDS were reported from 1998 to 2005 in Turkey.
This figure is lower than those reported from Europe (5).
The aim of this study was to investigate the allelic
frequencies of CCR5delta32 in a healthy northern
Turkish population to assess the genetic susceptibility to
HIV infection.

CCR5 gene allelic and genotypic frequencies were
compared and the differences evaluated using the chisquare (χ2) test (two-sided) for Hardy-Weinberg
equilibrium (HWE). The expected values were compared
with those observed by the χ2 test contingency tables. A
probability of less than 0.05 was required for statistical
significance.

Materials and Methods
A total of 449 unrelated healthy individuals (324 men
and 125 women; mean (range) age 43.7 (12-87) years
without any known history of HIV-1 infection were
enrolled from Ondokuz Mayis University between
January 1998 and May 2003. All subjects were of
Turkish origin and from the Black Sea coastal region and
gave informed consent to participate in this study.

Results
The prevalence of CCR5 genotypes was investigated
among 449 healthy individuals from northern Turkey.
Among the healthy subjects, 402 (89.8%) had CCR5 +/+
homozygosity and 47 (10.2%) had CCR5+/delta32
heterozygosity
(Table).
CCR5
delta32delta32
homozygosity was not observed among the healthy
controls. The frequency of the CCR5 allele was 5.2%.
Genotypic frequencies were in HWE (χ2=1.39; df=1;
P=0.758).

DNA was isolated from the heparinized peripheral
blood samples from all subjects using the ‘salting out’
method (6). 32-bp deletion polymorphism was
determined by polymerase chain reaction (PCR). PCR
amplification was performed in a programmable thermal
cycler (Techne Gradient, Cambridge, UK). The primers
(Iontec, Bursa, Turkey) were 5'-TCA AAA AGA AGG TCT
TCA TTA CAC C-3' forward and 5'-AGC CCA GAA GAG
AAA ATA AAC AAT C -3' reverse.

Table.

PCR reaction was performed in 25 µl, 1xPCR buffer
containing 20 pmol of each primer, 2.0 mM MgCl , 200
mM of each dNTP (MBI, Fermentas, Lithuania), 50 ng
DNA, and 1.0 U Taq polymerase (Promega, Madison, WI,
USA). Following initial denaturation at 94 ºC for 3
minutes, amplification was performed by 35 cycles of
denaturation at 94 °C for 75 seconds, annealing at 58 °C
for 75 seconds and extension at 72 °C for 1 minute. The
reaction was terminated by final extension at 72 °C for 7
minutes (7). The PCR produced a 241 bp product from
the wild-type allele and 209 bp product from the deleted
allele (Figure).

CCR5 genotype distribution in a Northern healthy Turkish
population.
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0.895

CCR5+/delta32

47

0.105

CCR5delta32/delta32

0

2

CCR5+/+

Total

449

CCR5 Alleles
CCR5+
CCR5∆32
Total

1

2

3

4

5

6

7

8

9

851

0.948

47

0.052

898

10 11 12

13

14

15

16

241 bp
209 bp
Figure.

18

Agarose gel electrophoresis of PCR products corresponding to the delta32 mutation
region. Lane 1-3, 5-9, 11, and 13-16 wild type (CCR5+/+); lane 4, 10, and 12
heterozygous (CCR5+/delta32).
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Discussion
The delta32 allelic frequency of the CCR5 gene shows
regional variations and differences among the population
samples. This is the first report on frequency of
CCR5delta32 polymorphism from northern Turkey. The
frequency of the delta32 allele of CCR5 in the non-HIV-1
infected northern Turkish population was 5.2%. Lucotte
et al. (11) reported that 32 allele frequency was 6.2% in
a small Turkish population consisting of 104 individuals.
Another study reporting from central Anatolia showed
that the allelic frequency of delta32 was 2.2% (9). Yigit
et al. (10) reported that all of the renal transplant
patients were homozygous for CCR5delta32 wild type
allele. The number of the individuals tested in present
study is relatively higher in comparison with earlier
studies. The differences in the reported frequencies of
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delta32 allele could be due to differing sample sizes,
heterogeneity of ethnic composition and latitudes of the
geographic areas under study. The results indicate that
frequency of CCR5 heterozygotes observed in this study
latitude was similar to those reported from other
countries in Europe that are in the same latitude with us
(10).
In conclusion, our results indicate that in relation to
geographic position, CCR5delta32 allele frequencies in
northern Turkey fit well in the observed north-south
gradient.
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